[1]
“PHARMACOVIGILANCE IN PRACTICE: ASSESSMENT OF REPORTED SERIOUS ADVERSE DRUG EVENTS IN NINEVEH HEALTH INSTITUTIONS”, Glob. j. public health med., vol. 8, no. 1 (Ongoing), pp. 270–286, Nov. 2026, doi: 10.37557/ps48an05.